RGEN Financial Facts
Investment income: 97KCost of product revenue: 11.24M
See Full Income Statement
Restricted cash: 450K
Accumulated deficit: -64.89M
See Full Balance Sheet
Repligen Corporation (RGEN) Earnings
|
Expand Research on RGEN
| Next EPS Date | 5/1/24 | EPS Growth Rate | -53.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +15.7% | Revenue Growth Rate | -17.9% |
| Average % Move 1-Wk after EPS | +7.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/24  |
Q124 | N/A | $0.30 | N/A | N/A | $150.06M |  |
N/A | N/A | ||
| 2/21/24 | Q423 | $0.33 | $0.33 | $0.00 | $155.7M | $155.38M | |
 | | Details | |
| 10/31/23 | Q323 | $0.23 | $0.16 | +$0.07 | $141.2M | $140.67M | = | | | Details | |
| 8/2/23 | Q223 | $0.53 | $0.48 | +$0.05 | $159.2M | $165.93M | = | | | Details | |
| 5/2/23 | Q123 | $0.64 | $0.59 | +$0.05 | $182.7M | $182.19M | = | | | Details | |
| 2/22/23 | Q422 | $0.68 | $0.58 | +$0.10 | $186.8M | $186.3M | = | | | Details | |
| 11/1/22 |
Q322 | $0.77 | $0.68 | +$0.09 | $200.7M | $192.68M | |
| | Details | |
| 8/2/22 | Q222 | $0.91 | $0.71 | +$0.20 | $207.6M | $189.6M | |
| | Details |
